Key Takeaways
- Companies are investing in XRP treasuries to improve cross-border payments, reduce costs, and explore long-term digital asset holdings.
- Improving laws could soon classify XRP as a commodity, clarifying regulatory treatment and encouraging institutional adoption and treasury experimentation.
- Corporate strategies include pilot programs, staking, pairing XRP with stablecoins, and establishing custody, audit, and compliance frameworks.
- Pending XRP ETF filings and Ripple’s RLUSD stablecoin could expand liquidity, operational use, and investment opportunities for businesses.
XRP, the native token of the XRP Ledger, enables ultra-fast settlement and low-cost cross-border transfers. Since its launch in 2012, XRP has navigated both rapid growth and legal turbulence, most notably the SEC’s lawsuit against Ripple.
In 2025, the case took a turn in Ripple’s favor, with critical charges dismissed. Momentum has since grown with the passing of the GENIUS Act and the advancement of the CLARITY Act, which establishes clear rules for stablecoin issuers such as Ripple’s RLUSD and could smooth the path for deep institutional adoption. Meanwhile, a slate of big name XRP ETF applications are pending. Speculation is mounting that the SEC will approve its first batch of XRP ETFs in early autumn, sucking liquidity out of the market and potentially fuelling a price surge.
With a constellation of big developments lining up in the XRP galaxy, it’s no surprise big investors are trying to front run a potential price explosion.
In this article, we explore the companies building XRP treasuries and the factors driving adoption.
10 Companies Building XRP Treasuries
| Company | Ticker | XRP Allocation |
|---|---|---|
| Trident Digital Tech Holdings | TDTH | $500 Million (planned) |
| Webus International | WETO | $300 Million Mandate |
| VivoPower International PLC | VVPR | $121 Million (raised) |
| Wellgistics Health | WGRX | $50 Million credit facility |
| Nature’s Miracle Holdings | NMHI | $20 Million |
| Hyperscale Data | GPUS | $10 Million |
| Worksport | WKSP | Six-figure (initial) |
| BC Bud Co | BCBC | CAD 250,000 |
| Flora Growth Corp | FLGC | $100,000 |
| Quantum BioPharma | QNTM | Undisclosed |
Trident Digital Tech Holdings — $500 Million
With a $500 million plan, this is one of the biggest corporate bets on an XRP treasury so far. Trident’s goal is to use XRP as a liquid, cross-border settlement asset and to provide on-ledger liquidity at scale. It mirrors institutional treasury playbooks we’ve seen with BTC and ETH treasuries, but tailored to XRP’s speed and cost profile.
A stake this large assumes deeper market rails ahead, such as ETFs, regulated custody, and on-chain liquidity products, positioning XRP as a working asset and a reserve-like diversifier.
Webus International — $300 Million Mandate
A $300 million mandate signals intent with room to move as markets and rules evolve. Expect a phased rollout that leans on dollar-cost averaging, OTC execution, and prudent yield options where XRPL-compatible.
Rather than a lump-sum splash, this structure lets the team scale into liquidity as custody capacity, compliance clarity, and price discovery improve. It’s a vote of confidence in XRP’s role in institutional payments, with flexibility to accelerate if ETF-driven depth materializes.
VivoPower International PLC — $100 Million
VivoPower’s plan to raise $100 million suggests a forward-leaning treasury strategy with earmarked proceeds for XRP exposure. For a company operating in capital-intensive sectors, holding XRP can provide settlement benefits and a liquid, 24/7 asset that may also integrate with supply-chain payments or energy-market remittances. Because funds are being raised, allocations will likely arrive in stages, guided by governance and risk controls.
Wellgistics Health — $50 Million Credit Facility
In healthcare and pharma distribution, faster settlement and lower cross-border friction can be meaningful. Wellgistics Health’s $50 million credit facility for an XRP treasury, therefore, comes as no surprise. It indicates a structured financing approach to building exposure.
An XRP treasury could back supplier payments, patient-finance programs, or intercompany transfers, while allowing the firm to participate in potential upside as regulatory clarity advances and institutional products, like ETFs, broaden access and liquidity.
Nature’s Miracle Holdings — $20 Million
Nature’s Miracle Holdings has launched an up to $20 million Corporate XRP Treasury program, funded initially through a portion of equity financing recently approved by the SEC. The company will acquire XRP tokens for long-term reserves, use staking mechanisms to generate yield, and engage with the Ripple ecosystem. Future expansion may involve additional equity issuance, strategic placements, or structured financing instruments.
CEO James Li highlighted that XRP can make international payments faster and cheaper. Clearer rules from the GENIUS Act help Nature’s Miracle use XRP safely, improve treasury management, work with major financial institutions, and potentially add value for shareholders.
Hyperscale Data — $10 Million
As artificial intelligence (AI) and cloud infrastructure spending grow, suppliers and customers increasingly operate across borders. Hyperscale Data’s $10 million allocation signals a measured but strategic bet on XRP’s utility for fast settlement and potential integration with data center ecosystem payments.
Using XRP to streamline payments or collateral flows for services and power contracts could provide operational benefits. A $10 million line also provides flexibility to scale exposure as ETF liquidity, stablecoin interoperability, and enterprise-grade custody continue to mature.
Worksport — Six-Figure Purchase
Worksport approved up to $5 million for cryptocurrency purchases, including XRP and Bitcoin, with an initial six-figure XRP acquisition. The firm plans to use up to 10% of surplus operational cash for digital asset reserves, citing inflation hedging and diversification as key benefits. The company made its initial purchase of XRP and Bitcoin to establish its treasury in January 2025.
BC Bud Co — $250,000
For companies in highly regulated sectors with cross-border suppliers or investors, XRP can serve as an optional settlement rail and a liquid asset for diversification. BC Bud Co’s $250,000 XRP allocation reflects an exploratory approach consistent with smaller-cap corporate treasuries.
The position size is large enough to warrant formal controls, yet modest enough to build institutional knowledge without outsized risk. If regulatory clarity continues to improve and institutional demand rises, companies at this scale can leverage learnings to expand their digital asset strategies.
Flora Growth Corp — $100,000
A $100,000 allocation by Flora Growth Corp to XRP anchors a broader $1 million crypto portfolio that includes Ethereum, Solana, and Sui. The position allows exploration of treasury use cases, staking opportunities, and participation in Ripple’s network.
The allocation supports the development of custodial relationships, compliance procedures, and audit trails, while providing insight into cross-border payments and regulatory impacts.
CEO Clifford Starke said the company is investing in blockchain projects to make its balance sheet stronger. The investment takes a long-term approach, letting the company test new uses for digital assets while preparing for future opportunities in finance.
Quantum BioPharma — Undisclosed
Quantum BioPharma has partnered with BitGo Trust Company to securely manage and store its cryptocurrency holdings, including XRP, Bitcoin, Solana, and DOGE. The company will leverage BitGo’s institutional-grade custody services, which feature multi-signature wallets, 100% cold storage, and insurance coverage to protect against theft, loss, or unauthorized access.
In their announcement, CEO Zeeshan Saeed emphasized that the partnership strengthens security and compliance as the company expands its engagement with digital assets, while positioning Quantum to integrate cryptocurrencies into its broader portfolio.
When Will the XRP ETF Be Approved?
Although numerous financial institutions have applied for a spot XRP ETF, approval depends largely on the SEC’s assurance of regulatory compliance and issuer transparency. The evolving legal landscape, especially under the CLARITY Act, which narrows SEC jurisdiction over assets defined as commodities, and the broader acceptance of XRP as such, could smooth the pathway.
Ripple’s RLUSD and compliance with the GENIUS Act help make the network more trustworthy and may reassure the SEC about stability. The exact timing is unclear, but a decision could come between late 2025 and early 2026, depending on the SEC’s review and market conditions.
Closing Thoughts
Corporate interest in XRP treasuries indicates that many companies are exploring how digital assets can enhance payments, liquidity, and portfolio diversification. Decisions often focus on choosing the right custodian, setting up internal controls, maintaining audit trails, and understanding regulatory requirements across jurisdictions.
Recent US legal developments may shape access, while pending XRP ETF filings could influence liquidity. Companies usually start with small pilot programs, develop policies, and coordinate accounting and tax considerations before expanding. Pairing XRP with regulated stablecoins can help meet operational needs, with allocations aligned to risk tolerance and cash management goals.
